Navigation Links
POZEN Announces Positive Outcome for PA 325 Proof of Concept Study

or proprietary rights and obtain necessary rights to third party patents and intellectual property to operate our business; our inability to operate our business without infringing the patents and proprietary rights of others; general economic conditions; the failure of any products to gain market acceptance; our inability to obtain any additional required financing; technological changes; government regulation; changes in industry practice; and one-time events, including those discussed herein and in our Quarterly Report on Form 10-Q for the period ended September 30, 2006. We do not intend to update any of these factors or to publicly announce the results of any revisions to these forward-looking statements.

Contact

POZEN Inc.
Bill Hodges, 919-913-1030
Chief Financial Officer
or
Fran Barsky, 919-913-1044
Director, Investor Relations


'"/>




Page: 1 2 3

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: POZEN Announces Positive Outcome for Proof Concept Study
(Date:11/20/2009)...NG, Pa., Nov. 20 In res...estions why currently available medications design...ored, ECRI Institute, an independent nonprofit org...n Finasteride for Prevention of Prostate Cancer ... New York Times article, " Drugs to Deter Some Ca...
(Date:11/19/2009)...., Nov. 19 BioCryst Phar... the pricing of a public offering of 5,000,000 sha...ing in gross proceeds of $48.75 million. All of t...o an effective shelf registration statement previo...sion. BioCryst has also granted the underwriters ...
(Date:11/19/2009)... 19 Riverain Medical announced tod...g Canadian medical imaging distributor Christie Gr...nGuard Chest Xray CAD. The exclusive agreement wil...ucts to the Canadian market through Christie Group...SoftView Enhanced Chest Imaging increases the clar...
Breaking Medicine Technology:ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2Scientists Test New Way to Get Drugs to Cancer Cells 53062 1Scientists Test New Way to Get Drugs to Cancer Cells 53062 2Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Monday August 3 2009 53060 1Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Monday August 3 2009 53060 2Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Monday August 3 2009 53060 3Holy Family Memorial Health Network Bolsters Patient Care Quality and Safety in Achieving Stage 6 on HIMSS Analytics EMR Adoption Model 28SM 29 Scale 53058 1Holy Family Memorial Health Network Bolsters Patient Care Quality and Safety in Achieving Stage 6 on HIMSS Analytics EMR Adoption Model 28SM 29 Scale 53058 2Holy Family Memorial Health Network Bolsters Patient Care Quality and Safety in Achieving Stage 6 on HIMSS Analytics EMR Adoption Model 28SM 29 Scale 53058 3Holy Family Memorial Health Network Bolsters Patient Care Quality and Safety in Achieving Stage 6 on HIMSS Analytics EMR Adoption Model 28SM 29 Scale 53058 4Holy Family Memorial Health Network Bolsters Patient Care Quality and Safety in Achieving Stage 6 on HIMSS Analytics EMR Adoption Model 28SM 29 Scale 53058 5
...ny Biosciences announced,today that the first pati...,valomaciclovir (EPB-348) for the treatment of her... is a highly potent anti-viral with enhanced,deliv...dose-finding study is an important milestone in,ou...ky, MD, Chief Executive,Officer. "Shingles, especi...
...tates that acidic treatments benefit poultry ...RT, La., Nov. 6 FreshFx Antimicrobial Solution,wh...cessing, was identified,in an October 2007 Watt Po...athogen reduction dilemma." Citing recent studies...eorgia Associate Professor of Poultry Science Scot...
Other Medicine Technology:Epiphany Biosciences Reports Initiation and Enrollment in Valomaciclovir Study for Shingles 2FreshFx Recognized for use in the Scalder as a Solution to the 'Yield/Pathogen Reduction Dilemma' 2
(Date:11/21/2009)..., LONDON, November 21, 2009 /PRNewswire-First...est Test Test Test Test Test Test Test Test Test T...est Test Test Test Test Test,Test Test Test Test T...More test More test More test More test More test ...More test More test More test More test More,test ...
(Date:11/21/2009)... Eric J. Hall, president and chi... of America (AFA) issued the following statement r...ection as part of the new annual wellness for Medi... and Affordable Care Act" that was introduced...NY (PRWEB) November 21, 2009 -- Eric J. Hall, pres...
(Date:11/20/2009)..., PRINCETON, NJ, Nov. 20 /PRNewswire-FirstCall/...hat a Special Meeting of Shareholders will be held...Meeting is to consider approval of two special res...ve and authorize the sale of all or substantially ... terms provided for in the asset purchase agreemen...
(Date:11/20/2009)... Senators and Congressmen in Com...ver their Health Care Vote , ...nators and congressmen running for re-election nex...cal guru Charlie Cook, may come to regret voting f...bill, according to a breaking Zogby International/...
(Date:11/20/2009)... , HAIFA, Israel, November 20 /PRNewswire-... (CVSL.OB), http://www.CVSLMEDICAL.COM , a leadin...hnology, today announced that,the company,s Board ...ations,in Europe, Canada and the Far East for its ...applicable for all angioplasty (PCTA) procedures. ...
Breaking Medicine News(10 mins):Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2
...le called RBP4 (retinol binding protein 4) is an i...f insulin resistance //, the main cause of type 2...bolic syndrome, according to a recent study. ...tifying individuals who are at risk of developing ...
... to develop human disease research, now proved 95 ... of extremely //complex virus - the vaccinia virus...archers at the La Jolla Institute for Allergy & Im...e to one of the most complex viruses known to man ...
... spells heaven for millions of avian influenza pat...e Children’s Research Hospital //. According to th...s potent against one antigenic variant of the avia...rus. The great thing about such vaccines is t...
...mpaign for removal of Union Health Minister Anbuma... today sought// removal of AIIMS Director P Venugo...hind the agitation by medical students in Delhi ag...nti-quota protests against 27 per reservation for ...
... of HIV positive patients in Bihar, a high profile...e legislature and those connected// with AIDS awar...d means for a more forceful drive against the drea...rces said. Top officials of National AIDS Co...
...senior BJP leader Sushma Swaraj today expressed co...ter A Ramadoss and AIIMS Director P Venugopal// , ... "I am very sad at what is happening concerni...ng there and it is churning out the best brains in...
Other Medicine News:Health News:A New Marker For Type-2 Diabetes ? 2Health News:Bioinformatics Made a Boon In Immune Response Study - LIAI Finds 2Health News:Bioinformatics Made a Boon In Immune Response Study - LIAI Finds 3Health News:Striking a Gold Mine: H5N1 Vaccine may Serve as an Antidote for Mutants and Variants 2
...RI TREK™ Compact Compressor is for active pa...nywhere and everywhere. The compressor is small an... source optionsworldwide AC compatibility (100 to ... patients the freedom to take aerosol treatments a...
...g Quieter Compressed Air., ,Allied Healthcares Ti...uch quieter than other air compressors that you ma.... The PCS 414 features a durable, mar-resistant st...e unit weighs only 26.5 pounds. The PCS 414 has be...
CompAir XLT Compressor Nebulizer System
CompAir Elite Compressor Nebulizer System
Medicine Products: